サマリー

また、遺伝子発現研究では、複数の遺伝子の発現プロファイルやパターンを調べることもあります。RNAシーケンシング（RNA-Seq）は、次世代シーケンシング（NGS）の利点を生かして、生体サンプル中のRNAをある時点で検出・定量します。

市場分析と洞察。NGSベースのRNA-sequencingの世界市場
NGSベースのRNA-sequencingの世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されています。
本レポートでは、業界標準の精度の高い分析と高いデータの完全性により、世界のNGSベースのRNA-sequencing市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、収益面での世界のNGSベースのRNA-sequencing市場全体の規模など、検証済みの信頼できる市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のNGSベースのRNA-sequencing市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のNGSベースのRNA-sequencing市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を採用しました。

世界のNGSベースのRNA-sequencingの範囲と市場規模
NGSベースのRNA-sequencing市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のNGS-based RNA-sequencing市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間における、タイプ別、アプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
合成によるシーケンシング
イオンセミコンダクターシーケンシング
単一分子リアルタイムシーケンシング
ナノポアシーケンシング

用途別セグメント
研究・学術機関
病院・診療所
製薬・バイオテクノロジー企業
その他

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
イルミナ
テルモフィッシャーサイエンティフィック
オックスフォード・ナノポア
アジレント・テクノロジー
BGI
パーキンエルマー
QIAGEN
ユーロフィンス・サイエンティフィック
ロシュ
タカラバイオ
ジェネウィズ
ハミルトン
マクロジェン
ザイモリサーチ
テカンジェノミクス

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2016-2027)
2.2 NGS-based RNA-sequencing Growth Trends by Regions
2.2.1 NGS-based RNA-sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NGS-based RNA-sequencing Historic Market Share by Regions (2016-2021)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Regions (2022-2027)
2.3 NGS-based RNA-sequencing Industry Dynamic
2.3.1 NGS-based RNA-sequencing Market Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top NGS-based RNA-sequencing Players by Revenue
3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2016-2021)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2016-2021)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2020
3.5 NGS-based RNA-sequencing Key Players Head office and Area Served
3.6 Key Players NGS-based RNA-sequencing Product Solution and Service
3.7 Date of Enter into NGS-based RNA-sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2016-2021)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2022-2027)

5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2016-2021)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2016-2027)
6.2 North America NGS-based RNA-sequencing Market Size by Type
6.2.1 North America NGS-based RNA-sequencing Market Size by Type (2016-2021)
6.2.2 North America NGS-based RNA-sequencing Market Size by Type (2022-2027)
6.2.3 North America NGS-based RNA-sequencing Market Size by Type (2016-2027)
6.3 North America NGS-based RNA-sequencing Market Size by Application
6.3.1 North America NGS-based RNA-sequencing Market Size by Application (2016-2021)
6.3.2 North America NGS-based RNA-sequencing Market Size by Application (2022-2027)
6.3.3 North America NGS-based RNA-sequencing Market Size by Application (2016-2027)
6.4 North America NGS-based RNA-sequencing Market Size by Country
6.4.1 North America NGS-based RNA-sequencing Market Size by Country (2016-2021)
6.4.2 North America NGS-based RNA-sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2016-2027)
7.2 Europe NGS-based RNA-sequencing Market Size by Type
7.2.1 Europe NGS-based RNA-sequencing Market Size by Type (2016-2021)
7.2.2 Europe NGS-based RNA-sequencing Market Size by Type (2022-2027)
7.2.3 Europe NGS-based RNA-sequencing Market Size by Type (2016-2027)
7.3 Europe NGS-based RNA-sequencing Market Size by Application
7.3.1 Europe NGS-based RNA-sequencing Market Size by Application (2016-2021)
7.3.2 Europe NGS-based RNA-sequencing Market Size by Application (2022-2027)
7.3.3 Europe NGS-based RNA-sequencing Market Size by Application (2016-2027)
7.4 Europe NGS-based RNA-sequencing Market Size by Country
7.4.1 Europe NGS-based RNA-sequencing Market Size by Country (2016-2021)
7.4.2 Europe NGS-based RNA-sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2016-2027)
8.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Type
8.2.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Application
8.3.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region
8.4.1 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America NGS-based RNA-sequencing Market Size (2016-2027)
9.2 Latin America NGS-based RNA-sequencing Market Size by Type
9.2.1 Latin America NGS-based RNA-sequencing Market Size by Type (2016-2021)
9.2.2 Latin America NGS-based RNA-sequencing Market Size by Type (2022-2027)
9.2.3 Latin America NGS-based RNA-sequencing Market Size by Type (2016-2027)
9.3 Latin America NGS-based RNA-sequencing Market Size by Application
9.3.1 Latin America NGS-based RNA-sequencing Market Size by Application (2016-2021)
9.3.2 Latin America NGS-based RNA-sequencing Market Size by Application (2022-2027)
9.3.3 Latin America NGS-based RNA-sequencing Market Size by Application (2016-2027)
9.4 Latin America NGS-based RNA-sequencing Market Size by Country
9.4.1 Latin America NGS-based RNA-sequencing Market Size by Country (2016-2021)
9.4.2 Latin America NGS-based RNA-sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2016-2027)
10.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Type
10.2.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Application
10.3.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country
10.4.1 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.1.5 Illumina Recent Development
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.2.5 Thermo Fischer Scientific Recent Development
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.3.5 Oxford Nanopore Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.4.5 Agilent Technologies Recent Development
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.5.5 BGI Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.6.5 PerkinElmer Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.7.5 QIAGEN Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.8.5 Eurofins Scientific Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.9.5 Roche Recent Development
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.10.5 Takara Bio Recent Development
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.11.5 GENEWIZ Recent Development
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.12.5 Hamilton Recent Development
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.13.5 Macrogen Recent Development
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.14.5 Zymo Research Recent Development
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2016-2021)
11.15.5 Tecan Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details